 |
|
|
| |
Ombitasvir/Paritaprevir/r and Dasabuvir With Ribavirin for HCV Genotype 1 Patients With Decompensated Cirrhosis
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco, CA
Parvez S Mantry1, John Hanson2, Roger Trinh3, Alnoor Ramji4, Linda Fredrick3, Li Liu3, Amit Khatri3, Prajakta Badri3, Leti cia Canizaro3, Manal Abunimeh3, Eric Cohen3, Nancy S Shulman3, Stuart C Gordon5
1The Liver Insti tute at Methodist Dallas, Dallas, Texas, United States; 2Charlott e Gastroenterology & Hepatology, PLLC, Charlott e, North Carolina, United States; 3AbbVie Inc., North Chicago, Illinois, United States; 4University of Briti sh Columbia, Vancouver, Briti sh Columbia, Canada;
5Henry Ford Health System, Detroit, Michigan, United States
|
| |
|
|
|
|
|
